Cancer Metastatic clinical trials

Explore recruiting cancer metastatic clinical trials.

Recruiting cancer metastatic studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cancer Metastatic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ACO/ARO/AIO-18.2 Preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure: A randomized phase III trial of the German Rectal Cancer Study Group

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

TIRACAN; Open label phase 2 basket trial with Atezolizumab and Tiragolumab in solid tumors

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Single cell characterization of persistent cells upon treatment with durvalumab (MEDI4736) with or without tremelimumab in MSS and MSI colorectal and endometrial tumors: the SERPENTINE clinical trial (Single cEll pRofiling PErsistaNce To ImmuNothErapy)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Measuring Oncological Value of Exercise and Statin (MOVES)

Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

PHASE Ib STUDY WITH THE COMBINATION OF LB−100 (PP2A INHIBITOR) AND AZENOSERTIB (WEE1 INHIBITOR) IN PATIENTS WITH METASTATIC COLORECTAL CANCER The COLLEE trial

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

(21140 ARANOTE) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide in addition to androgen deprivation therapy (ADT) versus placebo plus ADT in men with metastatic hormone-sensitive prostate cancer (mHSPC).

Spain, Latvia, Lithuania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cancer Metastatic trials by city

Cancer Metastatic in Toronto Cancer Metastatic in Vancouver Cancer Metastatic in Montreal Cancer Metastatic in Calgary Cancer Metastatic in Edmonton Cancer Metastatic in Ottawa Cancer Metastatic in Winnipeg Cancer Metastatic in Quebec City Cancer Metastatic in Hamilton Cancer Metastatic in Kitchener Cancer Metastatic in London Cancer Metastatic in Halifax Cancer Metastatic in New York Cancer Metastatic in Los Angeles Cancer Metastatic in Chicago Cancer Metastatic in Houston

Cancer Metastatic clinical trials

Recruiting cancer metastatic studies right now

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Propofol vs Sevo for Paediatric Tumor Surgery

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

Also recruiting in Europe

ACO/ARO/AIO-18.2 Preoperative FOLFOX versus postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure: A randomized phase III trial of the German Rectal Cancer Study Group

TIRACAN; Open label phase 2 basket trial with Atezolizumab and Tiragolumab in solid tumors

Single cell characterization of persistent cells upon treatment with durvalumab (MEDI4736) with or without tremelimumab in MSS and MSI colorectal and endometrial tumors: the SERPENTINE clinical trial (Single cEll pRofiling PErsistaNce To ImmuNothErapy)

Measuring Oncological Value of Exercise and Statin (MOVES)

PHASE Ib STUDY WITH THE COMBINATION OF LB−100 (PP2A INHIBITOR) AND AZENOSERTIB (WEE1 INHIBITOR) IN PATIENTS WITH METASTATIC COLORECTAL CANCER The COLLEE trial

(21140 ARANOTE) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide in addition to androgen deprivation therapy (ADT) versus placebo plus ADT in men with metastatic hormone-sensitive prostate cancer (mHSPC).

Cancer Metastatic trials by city

Other conditions